Bleeding patterns in children with Glanzmann thrombasthenia
Part of Blood & lymphatic clinical trials.
This study looks at the symptoms, severity, and outcomes of bleeding in children with Glanzmann thrombasthenia who are admitted to the hospital for active bleeding. It aims to understand the clinical pattern to improve care and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 month and 18 years old.
- Your child must have been diagnosed with Glanzmann thrombasthenia (a rare bleeding disorder where platelets don't stick together properly).
- Your child must be admitted to the hospital with active bleeding at the time of the study.
- Your child must not have other bleeding disorders (like hemophilia with inhibitors or any other cause of bleeding).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with Glanzmann thrombasthenia, a rare bleeding disorder. It aims to gather information about the condition and how it affects people, which may help improve care and treatment in the future.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This trial is testing a medication called eptacog beta (a clotting factor) to see if it helps control or prevent severe bleeding episodes in people with Glanzmann's thrombasthenia, a rare inherited bleeding disorder.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
This study is for people who have a history of unusual bleeding but whose standard blood tests have not found a known bleeding disorder. Researchers hope to learn more about what causes these unexplained bleeding problems.
Hear when a new Glanzemnn Thrombathenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.